Besnier Boeck disease Sarcoidosis
Conditions
Interventions
None listed
Sponsors
St. Antonius Ziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Clinical strong suspicion of sarcoidosis Alveolar lymphocytosis (>=15%) Histological confirmed sarcoidosis firstly presenting
Exclusion criteria
Exclusion criteria: previous steroid use , smoking
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| phenotypical analysis: 1 - expression of protein (absolute en percentual) 2 - intensity of protein expression per cel both in lavage-fluid and peripheral blood functional analysis: 1 - suppression of proliferation (%) 2 - cytokine measurement (concentration) in peripheral blood physiological analysis: measurement of auto-antibodies in peripheral blood genetic analysis: when abovementiones analyses show significant differences with respect to protein expression or cytokine production relevant genes (PTPN22, CTLA4, CD103, TGFβ-1) will be genotyped and screened for present polymorphisms. | — |
Countries
Netherlands
Outcome results
None listed